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Background: Podoconiosis is one of the most neglected tropical diseases, which untreated, causes considerable
physical disability and stigma for affected individuals. Little is known about the quality of life (QoL) of patients with
podoconiosis. This study aimed to assess the QoL of patients with podoconiosis in comparison with healthy
controls in Ethiopia.
Methods: A comparative cross-sectional study was conducted in May 2012, among 346 clinically confirmed adult
patients with podoconiosis, and 349 healthy adult neighbourhood controls in Dembecha woreda (district) in northern
Ethiopia. QoL was assessed using the validated Amharic version of the World Health Organisation Quality of Life
questionnaire (WHOQoL-BREF) scale; in addition, mental health and stigma were assessed by the Kessler-10 scale and
podoconiosis stigma scale respectively. Logistic regression analysis was done to identify factors associated with QoL.
Results: Patients with podoconiosis had significantly lower mean overall QoL than the controls (52.05 versus 64.39),
and this was also true in all four sub domains (physical, psychological, social and environmental). Controls were 7 times
more likely to have high (above median) QoL (Odds Ratio = 6.74, 95% Confidence Interval 4.62 to 9.84) than cases.
Factors associated with lower QoL were: experiencing high levels of stigma, living in an urban area, being illiterate,
having additional co-morbidities, and being unmarried. Mental illness was associated with lower scores in
psychological and physical domains.
Conclusions: Programs targeting podoconiosis interventions should include QoL as an indicator for monitoring
progress. Interventions targeting improvement of QoL among patients with podoconiosis should address depression,
stigma and other co-morbidities.
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Podoconiosis is a form of elephantiasis that predomin-
antly affects barefoot subsistence farmers in areas with
red volcanic soil [1]. It has been identified as an import-
ant neglected tropical disease (NTD) in East Africa,
South America and Asia [2-7], and is estimated to affect
1 million people in Ethiopia alone [8]. This neglected
tropical disease is characterised by bilateral swelling of
the lower legs with mossy and nodular changes to the
skin, and causes considerable disability [1]. The aetiology
is not fully understood, however current evidence suggests
that mineral particles from irritant volcanic soils have a
role, with some families having an additional genetic* Correspondence: kebededeka@yahoo.com
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reproduction in any medium, provided the orsusceptibility to the condition [9,10]. Podoconiosis follows
a chronic course, with progressively increasing disability,
especially with continued exposure to irritant soils. How-
ever, with simple treatment, the condition is reversible.
The disability and deformity caused by podoconiosis
have been shown to have economic and social conse-
quences [11,12]. These include isolation, and exclusion
from community events [13], but also difficulties finding
employment, gaining education and getting married
[12]. These are vital activities for both social and eco-
nomic well-being. The economic costs of the condition
are also high, with direct treatment costs being equiva-
lent to US$143 per patient per year [11]. In addition, the
physical challenges of the condition contribute to large
productivity losses [11]. As the majority of patients are
of working age, this has consequences for the widerl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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poorly understood by community members and health
care professionals alike, with misconceptions about aeti-
ology, infectiveness, and prognosis amongst others
[12,14]. Associated with this, it has been shown that
podoconiosis attracts a great deal of stigma, with many
negative attitudes and beliefs found about podoconiosis
in affected communities, as well as among patients
themselves [7,14].
WHO defines Quality of Life as “individuals’ percep-
tion of their position in life in the context of the culture
and value systems in which they live and in relation to
their goals, expectations, standards and concerns” [15].
This is affected by “physical health, psychological state,
level of independence, social relationships, personal be-
liefs and their relationship to salient features of their en-
vironment” [15]. Like most other categories of disease,
NTDs including lymphatic filariasis (LF), leprosy, trach-
oma and Buruli ulcer [16] have been found to decrease
quality of life. Neglected tropical diseases affect quality
of life both physically, through pain, disability, and other
symptoms such as itching, and socially, by reducing
productivity, marginalisation and causing stigma [16].
The stigma associated with these conditions as been
shown in turn to cause social isolation and exclusion, re-
lationship difficulties including reduced marriage pros-
pects, and negative feelings such as shame and lack of
self-esteem [16]. These factors are also present in
podoconiosis, which results in significant stigma, social
costs and physical difficulties [11,12,14,17].
In a literature search, thirteen studies were found that
assessed quality of life of patients with NTDs using
standardised scales. One of these looked at dermato-
logical quality of life in podoconiosis, and found a sig-
nificant reduction in quality of life comparable to other
dermatological conditions [18]; of the rest, five focused
on leprosy [19-23], five on lymphatic filariasis or
lymphoedema in general [24-28], and one each on trach-
oma [29] and cutaneous Leishmaniasis [30]. In addition,
there was one qualitative study of lymphatic filariasis
[31] which focused specifically on hydrocele in this
group. This focus group and interview-based study
found that LF hydrocele reduced physical activity and
created work, marital and sexual problems, and stigma.
Overall, the review suggested that these NTDs have a
significant impact on quality of life, no matter which of
the assessment scales were used. However, few of the
studies actually compared a patient group with healthy
controls, so other factors might reduce the score for a
community as a whole; having said this, those that did
include controls tended to find worse quality of life in
patients. Factors such as disability, deformity and dis-
crimination, which have been found to increase the asso-
ciation between other NTDs and quality of life, are alsofound in podoconiosis. In addition, these studies consist-
ently showed NTDs to exert the greatest effects in the
physical and psychological domains.
This review leads to the hypothesis that podoconiosis,
in common with the other NTDs, will have a significant
impact on the quality of life of sufferers. Whilst there
has been one study of the impact of podoconiosis on
dermatological quality of life [18], there is a lack of lit-
erature on the more general effect of podoconiosis on
quality of life. It is likely that podoconiosis has a large ef-
fect on quality of life of sufferers, and understanding this
better is essential for establishing the full burden of the
disease, planning appropriate services, and ensuring
podoconiosis is treated as a high priority condition in
local contexts.
Methodology
Study setting
The study took place in Dembecha woreda (district),
part of the West Gojjam zone of Amhara regional state,
northern Ethiopia, which has a population of 142,118.
The woreda is split into 29 kebeles (the smallest admin-
istrative unit), of which 25 are rural and 4 are urban. Just
14% of the population live in urban areas. The largest
ethnic group reported in Dembecha is Amhara (99.82%),
and Amharic is spoken as a first language by 99.87%.
The majority of the inhabitants of this region are Ethiop-
ian Orthodox Christians (98.47%), while 1.46% are
Muslim [32].
Podoconiosis has been found to be prevalent in this area.
In November 2011, a baseline survey prior to establishing
a podoconiosis treatment service in the area screened
51,017 individuals and identified 1,704 new cases of
podoconiosis [33]. Between June 2010 and late 2011, the
only podoconiosis services available near Dembecha were
45km away in the town of Debre Markos. Previous to this
there were no podoconiosis treatment services in the entire
Region. In 2011, the Debre Markos podoconiosis project
expanded to 6 satellite sites, including Dembecha. The sat-
ellite sites offer 3 months of treatment (hygiene, secondary
infections, wound care, bandaging, minor surgery and
manual lymphatic drainage therapy), training in self care,
and free shoes.
Seven kebeles within Dembecha woreda were selected
for the study. These were chosen on the basis of having
the highest prevalence of podoconiosis identified by the
above survey, and so the largest possible patient popula-
tion to sample. The study population constitutes those
patients identified by the 2011 survey, and their neigh-
bours without podoconiosis (Figure 1).
Study design and participants
The study used a questionnaire-based, comparative
cross-sectional study design. It compared two distinct
Figure 1 Map of the study area.
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adult patients with podoconiosis, and healthy adult
neighbours as controls. A quantitative methodology was
chosen for this study, as the primary aim was to estab-
lish whether decreased quality of life was associated with
podoconiosis.
Since the study was nested within one investigating
mental health, the sample size was calculated to investi-
gate differences in common mental disorder prevalence
between podoconiosis cases and healthy controls. Epi-Info
version 7.0 was used to calculate the number of cases and
controls necessary to have 80% power to detect a 10% dif-
ference between the two groups with 95% confidence
interval, based upon a 22.7% prevalence of mental dis-
order in the general population, as found in a previous
study in Ethiopia [34]. It was calculated that 315 partici-
pants were needed in each group. The target sample size
was 694 to take into account a predicted 10% non-
response rate. The final sample had 695 participants, 346
of whom were podoconiosis cases, and 349, controls.The cases were selected based on the population of
patients with podoconiosis identified in the aforemen-
tioned survey. 50 patients from each kebele were se-
lected. This was a near-total sample. Random selection
was not practically possible due to the wide distribution
of inhabitants within each kebele, and so convenience
sampling was used, with the first 50 patients on each list
who could be found being selected. The controls were
non-affected individuals neighbouring the cases. It was
decided, by picking a direction from a hat, that these
would be from the house to the right of the case’s house
to attempt to minimise bias due to discriminative selec-
tion by the data collectors. An attempt was made to
match controls to cases based on age and gender, as
these have been consistently shown to be strongly asso-
ciated with levels of quality of life [35,36]. However,
some of the data collectors found this was impossible in
certain cases, leading to the matching protocol being in-
consistently implemented. Participants under 15 years of
age were excluded.
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The primary variable of interest was quality of life, as
measured by the WHOQoL-BREF [36]. Potential con-
founders included age, gender, education, marital status,
place of residence, income, comorbidities, alcohol and
substance use, stigma, common mental disorders, and
podoconiosis stage. These were selected as they had pre-
viously been found to be factors associated with differ-
ences in quality of life in previous studies [37,38].
Three standardised and previously validated tools were
used. The WHOQoL-BREF [36] was used to assess qual-
ity of life in all participants, the Kessler-10 scale [39,40]
was used to assess mental health in all participants, and
the podoconiosis stigma scale [41] was used to assess felt
and enacted stigma among patients with podoconiosis
only. In addition, demographic and social variables were
assessed using a questionnaire adapted from previous
studies, and piloted before the study.
The WHOQoL-BREF scale [36] assesses quality of life
in 4 domains; physical health (7 items), psychological
health (6 items), social relationships (3 items), and envir-
onmental health (8 items). In addition, 2 items assess
general quality of life. This scale was developed by the
WHO as a shortened version of the QOL-100. WHO
QoL-BREF uses a 5-point scale for each answer, and
these are scored positively, with higher values meaning a
higher quality of life. Some negatively framed questions
must be inverted before analysis. The domain scores are
totalled and then converted to a 1–100 scale. The overall
quality of life score is calculated as a simple addition of
the scores for each question, and is on a 1 to 100 scale.
The Amharic translation used has been previously vali-
dated and used in Ethiopia mainly in relation to post-
conflict displacement [37,38,42,43].
The Kessler-10 scale [39,40] is a screening tool which
measures the likelihood of some form of common men-
tal disorder, such as depression or anxiety. The Amharic
translation has previously been validated and used in
Ethiopia for assessing common mental disorder in com-
parison with the gold standard of psychiatric assessment
[42-44]. The Amharic translation found the optimum
cut-off to be 16/17 for common mental disorders, with
sensitivity of 84.2% and specificity of 77.8% [44]. Previ-
ous studies have found excellent reliability of the scale,
with a reliability coefficient (Cronbach’s alpha) of be-
tween 0.90 and 0.93 [34,42-45].
The podoconiosis stigma scale [41] was developed spe-
cifically for patients with podoconiosis in Ethiopia, and
has been previously validated [41]. It has 4 independent
sections which assess felt and enacted stigma for pa-
tients and communities, and which are designed to be
used together or separately. Only the patient scales were
used for this study. The piloting of this scale found it
had excellent reliability, with a reliability coefficient(Cronbach’s alpha) of 0.955 for patient felt stigma, and
of 0.937 for patient enacted stigma [41].
Data collection procedures
The questionnaires were piloted before the study. The
pilot included seven patients and four controls who lived
within the nearest large urban area, Debre Markos.
Minor corrections were made to the wording of ques-
tions where these were unclear and to the layout to im-
prove clarity during completion by the collectors.
Data collection was carried over 5 days between 3rd
and 7th May 2012. The data were collected by 7 local
nurses, 1 per kebele, who were familiar with the local
area, had relevant medical background knowledge, and
were fluent in Amharic, the participants’ main language.
The questionnaires were used as the basis of structured
interviews, rather than self-completed, due to low liter-
acy levels. The data collectors received one day of train-
ing. This covered: the basics of podoconiosis and the
staging techniques; the objectives of the study and its
possible impacts; details of the questionnaire; taking in-
formed consent; matching criteria and sampling tech-
niques; and an opportunity to practice administering the
question followed by a debrief. Three of the authors
were supervisors (EM, KD, AT) and oversaw the data
collection process; two of these (KD, AT) were fluent in
Amharic. Each day the supervisors had contact with all
the data collectors to answer any queries, and reviewed
all of the questionnaires for missing data and inconsist-
encies. Questionnaires were returned for completion or
correction if there were problems. In addition, supervi-
sors checked the reliability of the data collectors by re-
interviewing a number of participants. This found that
the answers were broadly the same, and reliability of the
data collection was not considered to be a problem.
Data analysis
Data analysis was done using SPSS-19. Data were first
checked and cleaned, with missing values on the scales
replaced with the average of that item. Five question-
naires were excluded because they were incomplete.
Descriptive analysis of the social demographic distri-
butions and the degree of comparability of the case and
control groups was done. When comparing simple fre-
quencies, the chi2 test was used to establish significance;
when comparing means, the independent t test was used
to compare the mean differences in QoL level across
groups. Mean scores of the overall QoL, and 4 sub-
domains, were compared. Presence of mental disorder
was based on the cut-offs outlined above.
Logistic regression was performed for total QoL, and
for each of the physical and psychological sub-domains.
For the quality of life scores, the median of each scale
was calculated and used as a cut-off point between
Table 1 Basic characteristics of the study groups, patients with podoconiosis and healthy controls, Northern
Ethiopia, 2012
Variables Podoconiosis cases (%) Healthy controls (%) p value1
Gender Male 139 (40.2) 149 (42.7) 0.5502
Female 207 (59.8) 200 (57.3)
Age (years) Mean (Standard Deviation) 45.74 (13.190) 44.63 (12.903) 0.272
Range 15-80 15-85
15-24 10 (2.9) 16 (4.6) 0.495
25-34 63 (18.2) 58 (16.6)
35-44 79 (22.8) 95 (27.2)
45-54 92 (26.6) 77 (22.1)
55-64 75 (21.7) 76 (21.8)
65+ 27 (7.8) 27 (7.7)
Village Yechereka 50 (14.5) 50 (14.3) 1.000
Adis Alem 55 (15.9) 57 (16.3)
Lejat 43 (12.4) 43 (12.3)
Sazuri Dimela 48 (13.9) 49 (14.0)
Wad 50 (14.5) 51 (14.6)
Yetsed 50 (14.5) 48 (13.8)
Anigut Yedegera 50 (14.5) 51 (14.6)
Area of Residence Rural 339 (98.0) 339 (97.1) 0.636
Urban 7 (2.0) 10 (2.9)
Occupation Farmer 252 (72.8) 266 (76.2) 0.027
Traders 36 (10.4) 30 (8.6)
Employed 6 (1.7) 7 (2.0)
Daily Labourer 21 (6.1) 14 (4.0)
Housewife 0 11 (3.2)
Student 4 (1.2) 4 (1.1)
Jobless 16 (4.6) 11 (3.2)
Other 11 (3.2) 6 (1.7)
Ethnicity Amhara 346 (100.0) 349 (100.0) -
Literacy Literate 81 (23.4) 112 (32.1) 0.013
Not literate 265 (76.6) 237 (67.9)
School Attendance (of literate) No formal school 46 (56.8) 48 (42.9) 0.006
Primary (grade 1–6) 27 (33.3) 41 (36.6)
Secondary (grade 7–12) 8 (9.9) 23 (20.5)
Household Income (Birr/month) Mean (SD) 285.14 (206.42) 384.3 (263.38) <0.001
Min-Max 0-1500 0-1500
1st quintile (poorest) 86 (24.9) 53 (15.2) <0.001
2nd quintile 77 (22.3) 69 (19.8)
3rd quintile 79 (22.8) 54 (15.5)
4th quintile 56 (16.2) 82 (23.5)
5th quintile (richest) 48 (13.9) 91 (26.1)
Marital Status Married 198 (57.2) 265 (75.9) <0.001*
Unmarried 30 (8.7) 31 (8.9)
Divorced 63 (18.2) 34 (9.7)
Widowed 55 (15.9) 19 (5.4)
1P value was calculated using Chi-square test, 2P value was calculated using t test to compare mean difference.
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Table 2 Quality of life scores for patients with podoconiosis and healthy controls, Northern Ethiopia, 2012
Variables Podoconiosis cases Healthy controls Mean difference (95% CI)§ p value1
Overall WHOQoL-BREF Score Mean (SD) 52.05 (10.71) 64.39 (9.65) −12.35 (−13.87 to −10.83) <0.001
Physical Domain/100 Mean (SD) 47.89 (16.68) 68.12 (14.87) −20.23 (−22.58 to −17.87) <0.001
Psychological Domain/100 Mean (SD) 51.12 (18.18) 66.98 (17.38) −15.85 (−18.51 to −13.21) <0.001
Social Domain/100 Mean (SD) 52.12 (20.73) 67.16 (17.80) −15.05 (−17.92 to −12.17) <0.001
Environmental Domain/100 Mean (SD) 43.06 (17.31) 56.44 (15.57) −13.37 (−15.83 to −10.92) <0.001
§ Calculated using a two-sample t-test showing the mean difference.
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were 58.5, 57.2, and 58.3 for total QoL, physical and psy-
chological sub-domains respectively. For each dependent
variable, all the important variables were tested, and
those with a significant association were included in
multivariate analysis, in addition to variables shownTable 3 Logistic regression for high quality of life scores, usin
low quality of life scores on the WHOQOL-BREF
Variable Categories Low QoL
frequency
Disease Status Podoconiosis Case 252 (72.8)
Healthy Control 96 (27.5)
Gender Male 116 (40.3)
Female 232 (57.0)
Income 1st quintile (poorest) 98 (70.5)
2nd quintile 76 (52.1)
3rd quintile 66 (49.6)
4th quintile 54 (39.1)
5th quintile (richest) 54 (38.8)
Area of residence Rural 335 (49.4)
Urban 13 (76.5)
Literacy Literate 66 (34.2)
Illiterate 282 (56.2)
Age (years) 18-24 10 (38.5)
25-34 61 (50.4)
35-44 84 (48.3)
45-54 82 (48.5)
55-64 76 (50.3)
65+ 35 (64.8)
Other health problems Yes 72 (77.4)
No 276 (45.8)
Marital status Married 175 (37.8)
Unmarried 39 (63.9)
Divorced 75 (77.3)
Widowed 59 (79.7)
Stigma score High stigma score 142 (84.5)
Low stigma score 110 (61.8)
Common Mental Disorder No Common Mental Disorder 221 (44.8)
Common Mental Disorder present 127 (62.9)
§ adjusted for variables in the table.previously to impact upon the dependent variable. This
meant that occupation was excluded from all as being
not significant, and living in either rural or urban areas
was excluded from physical domain analyses. In addition,
stigma was excluded from the multivariate analysis as it
was only measured for cases and not controls.g a cut off of 58.50 (the median) to divide into high and
score
(%)
High QoL score
frequency (%)
Unadjusted
OR (95% CI)
Adjusted OR§
(95% CI)
p value
94 (27.2) 1 1 <0.001
253 (72.5) 7.06(5.06-9.86) 6.74 (4.62-9.84)
172 (59.7) 1.97 (1.45-2.67) 1.14 (0.74-1.75) 0.551
175 (43.0) 1 1
41 (29.5) 0.27 (0.16-0.44) 0.81 (0.42-1.55) 0.528
70 (47.9) 0.59 (0.37-0.94) 1.09 (0.60-1.95) 0.783
67 (50.4) 0.64 (0.40-1.04) 0.90 (0.50-1.63) 0.735
84 (60.9) 0.98 (0.61-1.60) 0.89 (0.50-1.60) 0.713
85 (61.2) 1 1
343 (50.6) 1 1
4 (23.5) 0.30 (0.09-0.93) 0.19 (0.05-0.71) 0.013
127 (65.8) 2.47 (1.75-3.49) 2.07 (1.36-3.21) 0.001
220 (43.8) 1 1
16 (61.5) 2.95 (1.12-7.76) 2.18 (0.65-7.37) 0.209
60 (49.6) 1.81 (0.93-3.52) 1.49 (0.66-3.38) 0.334
90 (51.7) 1.97 (1.05-3.72) 1.46 (0.68-3.12) 0.334
87 (51.5) 1.95 (1.04-3.69) 1.84 (0.86-3.94) 0.119
75 (49.7) 1.82 (0.96-3.46) 1.89(0.88-4.06) 0.102
19 (35.2) 1 1
21 (22.6) 1 1 0.012
326 (54.2) 4.05 (2.43-6.76) 2.20 (1.19-4.06)
288 (62.2) 1 1
22 (36.1) 0.34 (0.20-0.60) 0.34 (0.17-0.71) 0.004
22 (22.7) 0.18 (0.11-0.30) 0.26 (0.13-0.49) <0.001
15 (20.3) 0.15 (0.09-0.28) 0.31 (0.16-0.64) 0.001
68 (38.2) 1
26 (15.5) 3.71 (2.19-6.27)
272 (55.2) 2.08 (1.49-2.92) 1.21 (0.77-1.89) 0.412
75 (37.1) 1 1
Figure 2 Mean quality of life by disease stage (significant at p=0.035).
Table 4 Showing the reliability coefficient for the scales
used within the study
Scale Reliability coefficient
(Cronbach’s alpha)
Kessler 0.940
Felt Stigma scale 0.842
Enacted Stigma scale 0.920
Total WHOQoL-BREF score 0.918
Physical Domain score 0.806
Psychological Domain score 0.795
Social Domain score 0.776
Environmental Domain score 0.725
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correlation between the domains of the WHOQoL-BREF
were also assessed.
Regulatory approval and ethical issues
Ethical approval was sought and obtained from the Re-
search Governance and Ethics Committee of Brighton
and Sussex Medical School, and the Amhara Regional
Health Bureau. Written informed consent was sought
from all participants, with those who were unable to sign
leaving a thumbprint instead. When individuals aged <18
years were encountered, consent was obtained from their
parents or guardians. Data collectors were trained in key
ethical issues, including how to ensure informed consent,
as part of their initial briefing. All questionnaires were
anonymised and identifiable information stored separately
from the research data. Electronic data was kept on a
password-protected computer.
Results
Demographic characteristics
The groups were well matched on place of residence and
were comparable in terms of gender and age (Table 1). All
those in the study were Amhara in ethnic origin. However
there were some significant differences between the
podoconiosis and healthy control groups. The podoconiosis
group contained significantly more illiterate individuals
(p=0.013) and a higher proportion of people with lower
levels of education (p=0.006), particularly secondary educa-
tion; lower average income (p<0.001) and more individuals
in the lower income quintiles (p<0.001); and fewer married
individuals (p<0.001). The distribution of occupationswithin the two groups was also significantly different, with
the podoconiosis group containing fewer farmers and more
traders than the healthy group.Quality of life
Patients with podoconiosis had significantly lower mean
overall QoL scores than the controls (Table 2). The overall
mean QoL (SD) score among patients was 52.05 (10.71)
and 64.39 (9.65) among healthy controls (p<0.001), with a
mean difference of −12.35 (95% CI: -13.87 to −10.83). This
was also seen in all four sub domains (physical, psycho-
logical, social and environmental) (p<0.001). The largest
difference was seen in the physical domain, where the
mean difference was −20.23 (95% CI: -22.58 to −17.87).Factors influencing quality of life
Factors significantly associated with quality of life are
depicted in Table 3. Healthy controls were 6.7 times
Table 5 Showing the correlation between the domains of the WHOQOL-BREF score for this study
Physical QoL
domain
Psychological
QoL domain
Social QoL
domain
Environmental
QoL domain
Spearman's rho(correlation
coefficient)
Physical QoL domain 1
Psychological QoL
domain
0.623* 1
Social QoL domain 0.669* 0.483** 1
Environmental QoL
domain
0.585** 0.486** 0.589** 1
* Significant at p<0.01( two-tailed).
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tients with podoconiosis (OR=6.74, 95% CI: 4.62 to
9.84). Other factors associated with below-average QoL
scores included: experiencing high levels of stigma
(OR=3.705, 95% CI: 2.19 to 6.27), living in an urban area
(OR=0.19, 95% CI: 0.05 to 0.71), being illiterate
(OR=2.07, 95% CI: 1.36 to 3.21), having additional co-
morbidities (OR=2.12, 95% CI: 1.19 to 4.06), and being
unmarried. The same factors affected the physical and
psychological domains as the overall quality of life score.
In addition, absence of mental disorder was associated
with higher scores in the psychological (OR=1.98, 95%
CI: 1.30 to 3.02) and physical domains (OR=1.81, 95%
CI: 1.16 to 2.81), but not the overall QoL score
(OR=1.21, 95% CI: 0.77 to 1.89).
Mean scores on the WHOQoL-BREF showed some asso-
ciation with disease stage, decreasing as the disease became
more advanced; however the pattern was not consistent as
stage 4 had lower mean QoL scores than stage 5 (Figure 2).Figure 3 Comparison of WHOQoL-BREF scores for different diseases [Reliability of the tools used
All the tools were found to have good reliability, with
Cronbach’s alpha of greater than 0.7. The Kessler, enacted
stigma and overall QOL scales all showed excellent reli-
ability, with a reliability coefficient exceeding 0.9 (Table 4).
The four sub-domains of the WHOQOL-BREF were
found to all have significant correlation, showing good re-
liability of this scale, and the domain scores (Table 5).
Discussion
On the basis of evidence from other NTDs and the pre-
vious study of dermatological quality of life it was
hypothesised that podoconiosis would have a large nega-
tive effect on quality of life. The results of this study
support this hypothesis, with significant differences seen
between patients and controls in mean scores of all of
the domains of quality of life, and show an association
between podoconiosis and poor quality of life. The re-
gression analysis also supported this conclusion, and19,46].
Table 6 Collated results of WHOQOL and DLQI questionnaire in use in neglected tropical diseases
Study Country Disease Sample Overall WHOQOL score
(*denotes WHOQOL-BREF)
Joseph and Rao, 1999 [20] India Leprosy 50 treated patients 50 controls 94.5 101.5
Tsutumi et al., 2007 [23] Bangladesh Leprosy Patients Controls 78.61 (male)*, 74.21 (female)* 86.64 (male)*,
91.09 (female)*
Costa et al., 2012 [19] Brazil Leprosy 120 patients 50.0*
Wejesinghe and Wickremasinghe,
2010 [28]
Sri Lanka Lymphatic Filariasis 141 outpatients 128 healthy
controls
70% score <12.5, 30% score >12.5†
24% score <12.5, 76% score >12.5†
Fürst et al., 2012 [46] Côte d’Ivoire S. haematobium 225 51.9*
S. mansoni 225 47.7*
Hookworm 225 61.6*
T. trichiura 225 63.6*
Plasmodium spp 225 64.7*
Overall DLQI score
Chandrasena et al., 2007 [25] Sri Lanka Lymphatic filariasis 91 patients 8.2
Babu et al., 2006 [24] India Lymphatic Filariasis 203 patients 2.7
MacPherson, 2003 [26] Guyana Lymphatic Filariasis 15 patients 10.9
Legesse et al., 2008 [18] Ethiopia Podoconiosis 74 patients treated 74 patient
untreated
3 13
Schuster et al., 2011 [47] Brazil Cutaneous Larva Migrans 91 patients 5
11 Adults 6
80 children 5
†raw scores were not reported in this study, instead those scoring above and below the median value were shown, Dermatological Life Quality Index(DLQI) values
0–1 no effect, 2–3 small effect, 4–8 moderate effect, 9–16 large effect, 17–24 very large effect [47].
Figure 4 Picture of four female patients with podoconiosis
from Ethiopia.
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http://www.hqlo.com/content/11/1/122showed that patients with podoconiosis have almost
seven times the risk of healthy people for having a
below average score on this scale. This is in accordance
with the only other study of quality of life in
podoconiosis, which demonstrated low dermatological
quality of life among patients with podoconiosis [18].
In addition, it is also consistent with what is already
known about the social, psychological and economic
effects of podoconiosis [11,12,14,17].
These results also fit well with what is known about other
NTDs. When compared to the results of those studies that
used the same scales, the impact of podoconiosis was found
to be greater than other NTDs, particularly in the physical
and social domains [23,28,46,47] (Figure 3, Table 6). This
may be explained by the physical limitation caused by the
leg swelling that characterises podoconiosis. In addition,
previous studies have documented the social stigma due to
podoconiosis [11,12,14,17]. Widespread misconceptions
about podoconiosis may contribute towards stigma: studies
have documented that most patients with podoconiosis and
health providers believe that there is no treatment for
podoconiosis [14,17]. For other diseases, particularly leprosy
and lymphatic filariasis, patient are aware that treatment
and cure exist. This, plus the low coverage of treatment ser-
vices, may explain some of the differences found.
Most of the factors associated with QoL were consis-
tent with previous reports. These included experiencinghigh levels of stigma, living in an urban area, being
illiterate, having additional co-morbidities, and being un-
married. In addition, the presence of a mental health dis-
order was found to reduce physical and psychological
quality of life, and this has been found to be a consistent
predictor of low QoL in many studies [48,49]. Similarly,
being unmarried has been found to be a predictor of low
QoL [19]. It is also clear that other chronic health condi-
tions are likely to reduce quality of life, for the same rea-
sons as podoconiosis and the other NTDs. Stigma was
also found to significantly reduce the QoL of patients
with podoconiosis, as has been found for other NTDs
[21,23] (Figure 4).
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http://www.hqlo.com/content/11/1/122The study also found that the level of stigma experi-
enced by patients increased and their QoL decreased as
the disease stage became more severe. The most severe
stages of podoconiosis are characterised by one or both
of swelling above the knee and joint fixation in the feet,
leading to greater physical disability and increased de-
formity. In addition to the physical limitations, these pa-
tients may experience more stigma and discrimination
as they are easily identified. Similar findings have also
been reported among patients with lymphatic filariasis
and leprosy [21,25].
This study has several strengths. Firstly the study used
validated instruments for measuring QoL, common
mental disorders and stigma. Secondly the study in-
cluded healthy controls against which to compare the
QoL of patients with podoconiosis, which many of the
previous studies in NTDs lack. Nonetheless the study is
not without limitation. It could be argued that QoL is
better measured qualitatively by exploring patients’ life
experience and perceptions; however, as previous studies
have documented the social exclusions and stigma faced
by patients with podoconiosis, it was felt that the use of
standardized tools to quantify the extent of QoL among
patients with podoconiosis was a valuable addition to the
evidence, and would enable direct comparison with other
conditions. We did not measure the frequency of
‘acute attacks’ (variously termed acute adenolymphangitis
or acute dermatolymphangioadenitis). Acute attack fre-
quency appears to affect the QoL of patients with lymph-
atic filariasis, and might underlie some of the diminished
life quality measured among patients with podoconiosis.
Purposive sampling of the cases is also another limitation
of the study. Nonetheless, more than 75% of the cases in
the selected kebeles were included in the study.
Taking into account the above limitations, the results
have a number of implications for podoconiosis preven-
tion and treatment programmes. This study is the first
to demonstrate the effect of podoconiosis on general
quality of life, adding urgency to the task of reducing the
burden of podoconiosis in affected communities. Previ-
ous studies have documented the effectiveness of even
three months of simple hygiene and bandaging treat-
ment for patients with podoconiosis, which leads to
physical improvement of the feet and legs, with de-
creased swelling and mossy lesions [50,51]. This same
treatment has been shown to be linked to significant im-
provement in DLQI among patients [18], suggesting that
scale-up of this program would have considerable effects
on quality of life of more patients. Addressing the stigma
related to podoconiosis may also lead to improvement of
QoL of patients. Media campaigns with clear messages
that podoconiosis is preventable and treatable may
counter widespread misconceptions and mitigate the as-
sociated stigma. Social support for patients by localassociations may also mitigate internalized stigma and
improve self-esteem.
In conclusion, this study has demonstrated that pa-
tients with podoconiosis have significantly lower QoL
than healthy controls, both in the overall score and all
domains of QoL. It has also shown that patients with
podoconiosis have lower mean QoL scores than those
with other NTDs such as lymphatic filariasis and lep-
rosy. This indicates that programs focusing on treatment
of patients with podoconiosis should follow a holistic ap-
proach to address the psychological, social and environ-
mental impact of the disease, not just the physical
illness. Efforts to improve QoL of patients should give
priority to those with advanced disease, those who are
unmarried, those with co-morbidities and those with
low literacy.
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